Stay updated on Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.

Latest updates to the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe record history now includes a new revision v3.4.2 and removes v3.4.1 from the history. This update affects only the history log and not the study data.SummaryDifference0.1%

- Check16 days agoChange DetectedThe Record History shows a new revision entry (v3.4.1) added and the previous revision (v3.4.0) removed, reflecting an update to the study record's metadata.SummaryDifference0.1%

- Check30 days agoChange DetectedThe Record History page now shows a glossary toggle and uses green highlights for additions and red highlights for deletions, with the revision label updated from v3.3.4 to v3.4.0.SummaryDifference1%

- Check37 days agoChange DetectedRecord History now includes a new version entry v3.3.4 and removes the v3.3.3 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedThe Record History now includes a new revision entry (Revision: v3.3.3) and removes the HHS Vulnerability Disclosure and the previous Revision: v3.3.2 entries. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check87 days agoChange DetectedA new revision entry v3.3.2 is added to the Record History and the previous revision v3.3.1 is removed from the listing. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.